EMA’s revised reflection paper offers ‘snapshot’ of animal testing alternatives
Regulatory NewsJoanne S. EglovitchAdvanced therapies/cell and gene therapyBiotechnologyEuropeEuropean Medicines Agency (EMA)PharmaceuticalsPreclinical studyRegulatory writing/documentationResearch, Design and Development